What we do know Re UrocidinWhat we do know.
Endo commits $130 million for the right to Urocidin July 2009
Endo makes 1st milestone payment $6 million November 2009
Endo announce double milestone payment totaling $8 million Feb 2010
Endo also announces that it will exercise its right to assume world rights for Urocidin Feb 2010. 5 months ahead of their required schedule to do so and incurs additional cost accordingly
Endo refers to Urocidin as "the big one" during one of their webinar
Endo buys HealthTronics for $223 million for their patent equipment SYNERGO(R) which is design for urocidin application.
The bottom line. Endo has committed a few bucks towards urocidin and appears pretty darn sure that Urocidin is the real deal. Considering they are "in the know" these indicators listed above send a pretty clear message.
TC9